Skip to main content
Caplight Logo









LUMA Vision

LUMA Vision

Private
DublinHealthcare & Life Scienceshttps://lumavision.com/

Last Round

Series A

Extension

Dec 18, 2023

Total Funding Raised

$51M

Company Overview

LUMA Vision is a medical technology company that develops catheter-mounted, four-dimensional imaging and navigation platforms for interventional cardiology.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

cardiac imaging4D ultrasoundinterventional cardiologycatheter navigationmedical imagingelectrophysiologymedical AIcardiac catheterizationstructural heartdigital anatomyradiation reductionfluoroscopy alternativemedical devicemedtechimage guided surgery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

LUMA Vision Comparables

Compare LUMA Vision with similar companies based on industry and business-model similarity.

LUMA Vision comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Laza Medical
85%
YorLabs, Inc.
84%
Siemens Healthineers
78%

LUMA Vision Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionDec 18, 2023
Series A ExtensionOct 14, 2021
GrantOct 14, 2021
Series AJun 2, 2020

Key People

Founding team and executive leadership

Christoph Hennersperger

Co-Founder and Chief Technology Officer

Founding Team

Fionn Lahart

Co-Founder and Chief Executive Officer

Founding Team

David Smyth

Chief Financial Officer

Executive Team

LUMA Vision Investors

Notable investors and investment history

LUMA Vision investors
InvestorRounds
Atlantic Bridge CapitalSeries A Extension
European Innovation Council AcceleratorGrant
EQT Life SciencesSeries A Extension, Series A
imec.xpandSeries A Extension
Bayern KapitalSeries A Extension
Enterprise IrelandSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 1, 2025

    Monthly visitors increased 45% MoM.

  • May 1, 2025

    Monthly visitors grew 563% MoM.

LUMA Vision Filings

Explore SEC and related filing metadata, where available.

LUMA Vision filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about LUMA Vision's valuation, stock price, and market status.

Is LUMA Vision a public or private company?

LUMA Vision is a private company.

What is the current stock price of LUMA Vision?

LUMA Vision is a private company with no public stock price. No recent secondary market data is available.

How much is LUMA Vision worth (valuation)?

Valuation information for LUMA Vision is not publicly available.

Can I buy LUMA Vision stock?

LUMA Vision shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was LUMA Vision's last funding round?

LUMA Vision's most recent funding round was Series A Extension on December 18, 2023.

Who are the main investors in LUMA Vision?

Key investors in LUMA Vision include EQT Life Sciences, imec.xpand.

Will LUMA Vision IPO soon?

No public IPO plans have been announced for LUMA Vision.

How can I track LUMA Vision secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor LUMA Vision's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDublin
Employee Range78
Year Founded2017
Last FundingDec 18, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?